HealthEquity, Inc.

HQY Healthcare Health Information Services

HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025. In the quarter to July 2026, revenue grew 7.64%, EPS grew 14.5%, free cash flow fell 3.44% and total debt fell 7.53%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.

92.03 0.48 −0.52%
Market cap
$7.7B
P/E
33.0×
Fwd P/E
30.2×
Dividend yield
—
F-score
9/9
Altman Z
4.39
Beneish M
−2.77
Dividend safety
n/a
Older periods Oct '25 Jan '26 Apr '26 Jul '26
ROE

+8 more TTM periods

9.01% 10.19% 11.06% 11.43%
Piotroski F-Score
9 9 8 8
ROA
5.57% 6.30% 6.86% 7.07%
ROIC
6.54% 7.34% 7.85% 8.24%
Return on Tangible Assets
50.29% 60.01% 68.95% 75.98%
Average Days of Receivables
31.46 34.37 33.30 32.74
Free Cash Flow per Share
4.22 4.74 5.23 5.24
Free Cash Flow
362.67 408.32 441.25 436.95
Capital Expenditures
(52.26) (48.78) (48.63) (53.22)
Other line items
Cash ROIC
10.59% 12.07% 13.55% 13.75%
Accounts Receivable Turnover
11.84 10.87 11.23 11.67
Accounts Payable Turnover
27.87 30.19 28.30 43.06
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
17.13 11.09 13.24 8.01
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.22) (0.22) (0.23) (0.23)
Research and Development Expense of Revenue
19.90% 19.99% 20.10% 20.41%
Selling, General and Administrative Expense of Revenue
16.25% 16.38% 16.57% 16.87%
Share Based Compensation of Revenue
5.86% 5.56% 5.84% 5.97%
Interest Coverage
4.97 5.64 6.24 6.69
Operating CF/Net income
2.16 2.12 2.12 2.07
Depreciation/Fixed assets
46.08 49.01 40.79 32.87
Capex/Depreciation
(0.33) (0.31) (0.31) (0.34)
Revenue per Share
15.01 15.25 15.84 16.34
Operating CF per Share
4.83 5.31 5.80 5.88
Capex per Share
(0.61) (0.57) (0.58) (0.64)
Capex to Sales
0.04 0.04 0.04 0.04

Fold the line items

Columns are period end dates